CLOV vs PLX
Clover Health Investments Corp (CLOV) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported PLX revenue for 2024-12-31 was $53.4M. Net income was $2.9M. Revenue was down 18.5% from 2023-12-31 to 2024-12-31. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
CLOV currently screens at market cap $1.55B. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the CLOV and PLX stock pages for the full models.
Not investment advice.